https://www.washingtonexaminer.com/policy/healthcare/drugmakers-raise-prices-350-drugs
Drugmakers to raise prices of 350 drugs
at start of 2023
Washington Examiner, by Brady Knox
Posted By: Imright, 12/31/2022 8:39:08 PM
Drugmakers are set to raise the prices of 350 drugs at the beginning of 2023. Pfizer, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC, and Sanofi SA are among several drugmakers set to raise prices, according to healthcare research firm 3 Axis Advisors, Reuters reported. The price hikes are in response to a number of factors, mainly inflation, supply problems, and the Biden administration's Inflation Reduction Act, which will allow Medicare, the national government's health insurance program for seniors and people with certain disabilities, to negotiate several drug prices directly starting in 2026.